Starpharma Holdings reported AUD10.83M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 30.3M 0 Jun/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025